Beam Therapeutics, Inc. BEAM
NASDAQ · United States · Health Technology
$24.39-0.06 (-0.25%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -1.18 | -1.11 | -6.7% | $490.00K | -97.0% | +4.5%$25.91→$27.07 |
| Q1 2026 | 2026-05-07 | -0.91 | -1.01 | +9.9% | — | — | -0.1%$32.34→$32.32 |
| Q4 2025 | 2026-02-24 | 2.33 | -1.12 | +308.0% | — | — | +4.5%$28.33→$29.61 |
| Q3 2025 | 2025-11-04 | -1.10 | -1.01 | -8.9% | — | — | -4.9%$24.25→$23.07 |
| Q2 2025 | 2025-08-05 | -1.00 | -1.09 | +8.3% | — | — | — |
| Q1 2025 | 2025-05-06 | -1.24 | -1.17 | -6.0% | — | — | — |
| Q4 2024 | 2025-02-25 | -1.09 | -1.22 | +10.7% | — | — | — |
| Q3 2024 | 2024-11-05 | -1.17 | -1.16 | -0.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.